Malignant Melanoma
📧 Sign up to get email alerts when something new happens for Malignant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-31Clinical Trial Update: Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma [Phase 2]
This entry reports the withdrawal of a Phase 2 study evaluating two dose levels of RTA 402 in patients with advanced malignant melanoma.
-
CLINICAL_TRIALS withdrawal · 2024-09-23Clinical Trial Update: ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases [Phase 2]
Phase 2 trial evaluating ECT with pembrolizumab for unresectable melanoma with superficial or superficial and visceral metastases has been w…
-
CLINICAL_TRIALS withdrawal · 2017-02-08Clinical Trial Update: Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
The expanded access program for nivolumab in combination with ipilimumab in patients with unresectable or metastatic malignant melanoma is n…
-
CLINICAL_TRIALS withdrawal · 2009-09-09Clinical Trial Update: Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma [Phase 2]
A Phase 2 clinical trial evaluating interferon and lovastatin for malignant melanoma has been withdrawn.